Indeed, it was recently reported that in addition to terminal UPR signaling, imatinib also directly affects insulin secretion from beta cells [62] and promotes reactive oxygen species (ROS) scavenging by B cells in NOD mice, an effect which is essential for diabetes reversal [63]. This evidence concerns the gene INS and diabetes mellitus.